ADMA Biologics (ADMA) Financials: Revenue & Earnings
ADMA$11.16-0.01 -0.10%
$2.50B
Market Cap
14.83
P/E
14.01
Forward P/E
—
Score
ADMA Biologics (ADMA) Financials: Revenue & Earnings
ADMA price $11.16 -0.01 -0.10%
- Ticker
- ADMA
- Price
- $11.16
- Change
- -0.01 -0.10%
- Market cap ?
- $2.50B
- P/E ?
- 14.83
- Forward P/E ?
- 14.01
- Dividend yield ?
- 0.00%
- Beta ?
- 0.77
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 10661037 | 22760560 | 16985290 | 29349083 | 42219783 | 80943000 | 154080000 | 258215000 | 426454000 | 510173000 |
ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV…
Fair value
ADMA fair value $25.24. Price $11.16. Price is 56% below fair value.
Below fair value, and cheaper than usual. A larger discount than on 74% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 47.25M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 223.98M. Net debt -7.75M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 0.20 | — | 138.11M |
| 2026-08-05 | 0.16 | 0.16 | 124.39M | 125.34M |
| 2026-05-06 | 0.19 | 0.19 | 114.49M | 139.98M |
| 2026-02-25 | 0.20 | 0.18 | 139.16M | 139.60M |
| 2025-11-05 | 0.16 | 0.16 | 134.22M | 139.80M |
| 2025-08-06 | 0.15 | 0.14 | 121.98M | 130.30M |
| 2025-05-07 | 0.14 | 0.16 | 114.80M | 121.80M |
| 2025-03-03 | 0.14 | 0.15 | 117.55M | 108.65M |
| 2024-11-07 | 0.15 | 0.13 | 119.84M | 113.40M |
| 2024-08-08 | 0.13 | 0.08 | 107.19M | 86.41M |
| 2024-05-09 | 0.08 | 0.06 | 81.88M | 77.27M |
| 2024-02-28 | 0.04 | -0.01 | 73.90M | 72.15M |
| 2023-11-08 | 0.01 | 0.00 | 67.27M | 68.49M |
| 2023-08-09 | -0.02 | -0.02 | 60.12M | 55.50M |
| 2023-05-10 | -0.03 | -0.05 | 56.91M | 53.41M |
| 2023-03-23 | -0.06 | -0.07 | 49.98M | 45.93M |
| 2022-11-09 | -0.08 | -0.08 | 41.09M | 34.48M |
| 2022-08-10 | -0.07 | -0.09 | 33.91M | 31.81M |
| 2022-05-11 | -0.10 | -0.08 | 29.10M | 25.90M |
| 2022-03-24 | -0.09 | -0.10 | 26.38M | 21.76M |
| 2021-11-10 | -0.13 | -0.15 | 20.68M | 23.44M |
| 2021-08-11 | -0.15 | -0.15 | 17.83M | 17.83M |
| 2021-05-12 | -0.16 | -0.17 | 16.05M | 14.55M |
| 2021-03-25 | -0.20 | -0.17 | 13.96M | — |
| 2020-11-05 | -0.19 | -0.21 | 10.28M | 10.28M |
| 2020-08-05 | -0.23 | -0.19 | 7.79M | 5.42M |
| 2020-05-06 | -0.26 | -0.13 | 10.20M | 9.47M |
| 2020-03-12 | -0.18 | -0.20 | 12.04M | 11.37M |
| 2019-11-06 | -0.19 | -0.22 | 7.22M | 8.74M |
| 2019-08-08 | -0.25 | -0.26 | 6.56M | 7.61M |
| 2019-05-08 | -0.31 | -0.32 | 3.53M | 4.03M |
| 2019-03-13 | -0.39 | -0.33 | 4.06M | 3.64M |
| 2018-11-08 | -0.33 | -0.33 | 4.23M | 3.97M |
| 2018-08-10 | -0.35 | -0.32 | 4.66M | 4.12M |
| 2018-05-14 | -0.35 | -0.27 | 4.04M | 3.21M |
| 2018-03-05 | -0.24 | -0.51 | 12.00M | 12.83M |
| 2017-11-03 | 0.59 | -0.51 | 4.73M | 3.42M |
| 2017-08-11 | -0.55 | -0.42 | 3.40M | 2.52M |
| 2017-05-12 | -0.51 | -0.22 | 2.63M | 2.61M |
| 2017-02-24 | -0.35 | -0.33 | 3.33M | 3.04M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-24 | Kestenberg-Messina Kaitlin M. | Sell | 3.18K | $8.37 | 26.59K |
| 2026-07-16 | Kohler Terry | Buy | 85.13K | — | — |
| 2026-07-16 | Kohler Terry | Buy | 136.36K | $8.81 | 1.20M |
| 2026-05-27 | Grossman Jerrold B | Buy | 6.40K | $7.91 | 50.62K |
| 2026-05-12 | Grossman Jerrold B | Buy | 12.50K | $8.01 | 100.12K |
| 2026-05-11 | Grossman Jerrold B | Buy | 12.50K | $8.01 | 100.12K |
| 2026-04-01 | Kestenberg-Messina Kaitlin M. | Sell | 20.36K | $9.11 | 185.50K |
| 2026-03-17 | Guiheen Lawrence P. | Sell | 30.00K | $3.66 | 109.80K |
| 2026-03-17 | Guiheen Lawrence P. | Buy | 30.00K | $3.66 | 109.80K |
| 2026-03-16 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2026-03-16 | Grossman Adam S | Sell | 15.00K | $15.16 | 227.40K |
| 2026-03-16 | Grossman Adam S | Sell | 6.00K | $15.16 | 90.96K |
| 2026-03-16 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2026-03-13 | Guiheen Lawrence P. | Buy | 30.00K | $3.66 | 109.80K |
| 2026-03-13 | Guiheen Lawrence P. | Sell | 30.00K | $3.66 | 109.80K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Buy | 2.17K | $1.55 | 3.37K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Buy | 1.52K | $2.35 | 3.58K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Buy | 2.65K | $2.83 | 7.49K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Buy | 1.25K | $4.31 | 5.39K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Buy | 2.50K | $5.00 | 12.50K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 91.27K | — | — |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 10.10K | $15.63 | 157.80K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 2.17K | $1.55 | 3.37K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 2.65K | $2.83 | 7.49K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 2.50K | $5.00 | 12.50K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 1.52K | $2.35 | 3.58K |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Sell | 1.25K | $4.31 | 5.39K |
| 2026-03-07 | Kestenberg-Messina Kaitlin M. | Sell | 4.24K | $15.39 | 65.18K |
| 2026-03-07 | Grossman Adam S | Sell | 29.51K | $15.39 | 454.21K |
| 2026-03-06 | Kestenberg-Messina Kaitlin M. | Sell | 10.06K | $15.39 | 154.81K |
| 2026-03-06 | Grossman Adam S | Sell | 56.44K | $15.39 | 868.58K |
| 2026-03-06 | ELMS STEVE | Buy | 7.00K | $15.39 | 107.73K |
| 2026-03-05 | ELMS STEVE | Buy | 7.00K | $15.67 | 109.69K |
| 2026-02-26 | Grossman Adam S | Sell | 54.86K | $15.18 | 832.74K |
| 2026-02-26 | Kohler Terry | Other | 0 | — | — |
| 2026-02-26 | Kohler Terry | Other | 91.17K | $19.39 | 1.77M |
| 2026-02-19 | Kestenberg-Messina Kaitlin M. | Sell | 8.16K | $16.32 | 133.19K |
| 2026-02-19 | Grossman Adam S | Sell | 24.79K | $16.32 | 404.62K |
| 2026-02-19 | Tade Brad L. | Sell | 6.48K | $16.32 | 105.74K |
| 2026-02-17 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2026-02-17 | Grossman Adam S | Sell | 15.00K | $16.08 | 241.20K |
| 2026-02-17 | Grossman Adam S | Sell | 6.00K | $16.08 | 96.48K |
| 2026-02-17 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2026-02-09 | Grossman Jerrold B | Buy | 10.69K | — | — |
| 2026-02-09 | Grossman Jerrold B | Buy | 17.73K | $16.37 | 290.24K |
| 2026-02-09 | Kestenberg-Messina Kaitlin M. | Buy | 91.63K | — | — |
| 2026-02-09 | Kestenberg-Messina Kaitlin M. | Buy | 144.23K | $16.37 | 2.36M |
| 2026-02-09 | Grossman Adam S | Buy | 282.53K | — | — |
| 2026-02-09 | Grossman Adam S | Buy | 444.71K | $16.37 | 7.28M |
| 2026-02-09 | KWON YOUNG | Buy | 10.69K | — | — |
| 2026-02-09 | KWON YOUNG | Buy | 17.73K | $16.37 | 290.24K |
| 2026-02-09 | FINGER ALISON CECILY | Buy | 10.69K | — | — |
| 2026-02-09 | FINGER ALISON CECILY | Buy | 17.73K | $16.37 | 290.24K |
| 2026-02-09 | Salas Eduardo Rene | Buy | 10.69K | — | — |
| 2026-02-09 | Salas Eduardo Rene | Buy | 17.73K | $16.37 | 290.24K |
| 2026-02-09 | Guiheen Lawrence P. | Buy | 10.69K | — | — |
| 2026-02-09 | Guiheen Lawrence P. | Buy | 17.73K | $16.37 | 290.24K |
| 2026-02-09 | ELMS STEVE | Buy | 10.69K | — | — |
| 2026-02-09 | ELMS STEVE | Buy | 17.73K | $16.37 | 290.24K |
| 2025-12-15 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-12-15 | Grossman Adam S | Sell | 15.00K | $19.79 | 296.85K |
| 2025-12-15 | Grossman Adam S | Sell | 6.00K | $19.79 | 118.74K |
| 2025-12-15 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-11-19 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-11-19 | Grossman Adam S | Sell | 15.00K | $16.00 | 240.00K |
| 2025-11-19 | Grossman Adam S | Sell | 6.00K | $16.00 | 96.00K |
| 2025-11-19 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-10-24 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-10-24 | Grossman Adam S | Sell | 15.00K | $16.00 | 240.00K |
| 2025-10-24 | Grossman Adam S | Sell | 6.00K | $16.00 | 96.00K |
| 2025-10-24 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-09-15 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-09-15 | Grossman Adam S | Sell | 15.00K | $16.13 | 241.95K |
| 2025-09-15 | Grossman Adam S | Sell | 6.00K | $16.13 | 96.78K |
| 2025-09-15 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-08-15 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-08-15 | Grossman Adam S | Sell | 15.00K | $16.88 | 253.20K |
| 2025-08-15 | Grossman Adam S | Sell | 6.00K | $16.88 | 101.28K |
| 2025-08-15 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-07-30 | Kestenberg-Messina Kaitlin M. | Buy | 2.50K | $8.98 | 22.45K |
| 2025-07-30 | Kestenberg-Messina Kaitlin M. | Sell | 1.21K | $18.59 | 22.46K |
| 2025-07-30 | Kestenberg-Messina Kaitlin M. | Sell | 2.50K | $8.98 | 22.45K |
| 2025-07-24 | Kestenberg-Messina Kaitlin M. | Sell | 3.03K | $17.31 | 52.40K |
| 2025-07-24 | Tade Brad L. | Sell | 7.12K | $17.31 | 123.30K |
| 2025-07-15 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-07-15 | Grossman Adam S | Sell | 15.00K | $18.66 | 279.90K |
| 2025-07-15 | Grossman Adam S | Sell | 6.00K | $18.66 | 111.96K |
| 2025-07-15 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-06-26 | Tade Brad L. | Sell | 9.84K | $18.40 | 181.02K |
| 2025-06-16 | Grossman Adam S | Buy | 15.00K | $5.40 | 81.00K |
| 2025-06-16 | Grossman Adam S | Sell | 15.00K | $20.81 | 312.15K |
| 2025-06-16 | Grossman Adam S | Sell | 6.00K | $20.81 | 124.86K |
| 2025-06-16 | Grossman Adam S | Sell | 15.00K | $5.40 | 81.00K |
| 2025-06-16 | ELMS STEVE | Sell | 194.75K | $20.24 | 3.94M |
| 2025-06-13 | ELMS STEVE | Buy | 37.54K | $5.40 | 202.72K |
| 2025-06-13 | ELMS STEVE | Buy | 51.63K | $3.35 | 172.96K |
| 2025-06-13 | ELMS STEVE | Buy | 53.17K | $1.67 | 88.80K |
| 2025-06-13 | ELMS STEVE | Sell | 137.93K | $20.82 | 2.87M |
| 2025-06-13 | ELMS STEVE | Buy | 55.00K | $2.35 | 129.25K |
| 2025-06-13 | ELMS STEVE | Buy | 15.00K | $2.92 | 43.73K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 341, holders -33 vs prior quarter. Ownership 89.99%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 38.36M | 1.52M | +4.14% | 321.04M |
| STATE STREET CORP | 17.12M | 3.03M | +21.53% | 143.26M |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.10M | -203.06K | -1.97% | 84.57M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10.09M | 1.22M | +13.75% | 84.44M |
| RUBRIC CAPITAL MANAGEMENT LP | 9.34M | 7.53M | +416.16% | 78.17M |
| CAPITAL RESEARCH GLOBAL INVESTORS | 8.76M | -2.43M | -21.76% | 73.29M |
| FIRST TRUST ADVISORS LP | 7.80M | 7.44M | +2064.90% | 65.27M |
| GEODE CAPITAL MANAGEMENT, LLC | 6.06M | 235.87K | +4.05% | 50.73M |
| CALIGAN PARTNERS LP | 5.73M | 5.43M | +1808.34% | 47.92M |
| D. E. SHAW & CO., INC. | 5.27M | 4.71M | +840.50% | 44.15M |
| DIMENSIONAL FUND ADVISORS LP | 3.61M | -1.40M | -27.95% | 30.18M |
| GOLDMAN SACHS GROUP INC | 3.51M | 710.05K | +25.33% | 29.41M |
| B GROUP, INC. | 3.26M | 55.00K | +1.71% | 27.31M |
| NUVEEN, LLC | 3.26M | -2.84M | -46.54% | 27.29M |
| DUQUESNE FAMILY OFFICE LLC | 2.78M | 1.24M | +80.13% | 23.30M |
| NORTHERN TRUST CORP | 2.42M | 138.66K | +6.09% | 20.22M |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 2.36M | 2.36M | New | 19.75M |
| MORGAN STANLEY | 2.27M | -168.94K | -6.94% | 18.96M |
| RANGER INVESTMENT MANAGEMENT, L.P. | 2.12M | -168.39K | -7.37% | 17.71M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.09M | -3.18K | -0.15% | 17.52M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 2.09M | 2.09M | New | 17.52M |
| TWO SIGMA INVESTMENTS, LP | 2.02M | -72.25K | -3.45% | 16.91M |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.76M | 1.34M | +326.68% | 14.69M |
| VANGUARD FIDUCIARY TRUST CO | 1.65M | 17.05K | +1.04% | 13.85M |
| FUNDSMITH LLP | 1.65M | 0 | 0.00% | 13.81M |
Earnings and financials
ADMA Biologics, Inc. (ADMA) trades at $11.16, with a market cap of $2.50B and a trailing P/E of 14.83. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 10661037 | 22760560 | 16985290 | 29349083 | 42219783 | 80943000 | 154080000 | 258215000 | 426454000 | 510173000 |
Insights · Dividends · Forecast · Financials · Learn